Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing ...

Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...

A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma ...

Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of...

St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor,...

Using a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 genetic changes that can contribute...

Children suffering from rhabdomyosarcoma, a rare cancer of the muscle tissue, may have better chances for a cure if they have extended...

A serious childhood cancer takes advantage of a quality control mechanism that usually protects cells from stress-induced damage to...

A new gene test can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma, new...

Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Read...